METiS Secures RMB 400M Series D to Drive Biopharma Innovation in Beijing

METiS Secures RMB 400M Series D to Drive Biopharma Innovation in Beijing

With fresh capital and big vision, METiS accelerates drug discovery in China’s booming life sciences hub.
Legal framework sought for Vietnam’s biopharma sector

Legal framework sought for Vietnam’s biopharma sector

While players are betting much more on the high growth potential in Vietnam’s biopharma sector, they are still struggling to move ahead because of legal holes that prevent strong international partnerships.